Chief executive officer
United States of America
Before founding EGeen in 2001, Kalev Kask worked at the neurogenomics company AGY Therapeutics of South San Francisco, Stanford University, Asper Biotech and Toshiba. He completed his graduate degree with Prof. Tamas Bartfai at Stockholm University and post-doctoral training with Prof. Peter Seeburg at the Max-Planck Institute for Medical Research in Heidelberg. Dr. Kask has authored numerous scientific publications and patents.